Cardiology
Gillmore Staging for ATTR Cardiomyopathy calculator
Enter the published formula inputs below to calculate and interpret this score.
Clinical inputs
Allowed range: 10–100000 ng/L
Enter ng/L. The same number is used when the laboratory reports pg/mL.
Allowed range: 5–160 mL/min/1.73 m²
Result
2 fields remaining
Anyone can run this calculator. Sign in to save, favourite, or send the result.
Ruqelo is AI and can make mistakes. Check important information.
Clinical inputs
- NT-proBNP (ng/L)Accepted range: 10 to 100000
- Estimated GFR (mL/min/1.73 m²)Accepted range: 5 to 160
Primary source
Gillmore JD et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. DOI: 10.1093/eurheartj/ehx589. PMID: 29048471. Stage I is NT-proBNP ≤3000 ng/L and eGFR ≥45 mL/min/1.73 m². Stage III is NT-proBNP >3000 ng/L and eGFR <45 mL/min/1.73 m². Every other combination is stage II. In the National Amyloidosis Centre cohort, median survival was 69.2, 46.7, and 24.1 months. (2018)
View source